Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
430 participants
OBSERVATIONAL
2020-03-01
2020-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Immune Response in COVID-19 Patients
NCT04438629
Follow-up of Patients With Previous SARS-CoV-2 Infection: Long-term Damage Assessment
NCT05359159
Institutional Registry on Outpatient and Hospitalized COVID-19 Infected Patients
NCT04839107
Observational Study in COVID-19 Patients Treated With Remdesivir
NCT05239988
Detection of Anti-COVID-19 Antibody Levels in an Hospital Population
NCT04387929
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Serological and microbiological samples (blood samples, fecal samples and nasal/rectal swabs) are collected within 48 hours after admission and during the hospital stay, according with routine internal procedures.The biological samples are stored at the University Laboratory for Medical Research (Laboratorio Universitario di Ricerca Medica, LURM).
A dedicated database has been created and implemented to collect all the above mentioned information.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
not applicable (observational study)
not applicable (observational study)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All ages;
* All genders;
* Informed consent obtained.
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda Ospedaliera Universitaria Integrata Verona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Evelina Tacconelli
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Verona
Verona, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COVID19-VR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.